Search / 183 results found

from
to
  • Updated

NEW YORK, Dec. 1, 2021 /PRNewswire/ -- The "Compressors Market by End-user and Geography - Forecast and Analysis 2021-2025" report has been added to Technavio's offering. The compressor market growth potential will grow by USD 10.31 billion from 2020 to 2025. The market growth momentum is likely to progress at a CAGR of 2.67% during the forecast period. 

  • Updated

NEW YORK, Nov. 30, 2021 /PRNewswire/ -- S&P Dow Jones Indices (S&P DJI) today released the latest results for the S&P CoreLogic Case-Shiller Indices, the leading measure of U.S. home prices. Data released today for September 2021 show that home prices continue to increase across the U.S. More than 27 years of history are available for the data series and can be accessed in full by going to https://www.spglobal.com/spdji/.

  • Updated

NEW YORK, Nov. 29, 2021 /CNW/ - Galaxy Digital Holdings Ltd. (TSX: GLXY) ("GDH Ltd." or the "Company") is pleased to announce that Galaxy Digital Holdings LP (the "Issuer" and together with GDH Ltd., "Galaxy Digital") has agreed to issue and sell $500 million aggregate principal amount of 3.00% Exchangeable Senior Notes due 2026 (the "Notes") to certain purchasers, including affiliates of Arca, NZ Funds, Senator Investment Group and XN (the "Noteholders"), in a private placement under the Securities Act of 1933, as amended (the "Securities Act").

  • Updated

NEW YORK, Nov. 25, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Novavax, Inc. ("Novavax" or the "Company") (NASDAQ: NVAX) and certain of its officers.  The class action, filed in the United States District Court for the District of Maryland, Southern Division, and docketed under 21-cv-02910, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Novavax securities between March 2, 2021 and October 19, 2021, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.